Pay attention to the key dynamics of Injective.
Although the market is poor, Injective's on-chain activity has reached a historical milestone of 2.8 billion transactions, with daily active users stabilizing at 81,000.
As an established public chain focused on finance, the Injective team has been making progress.
Technically, the MultiVM architecture has been upgraded again:
Injective, as the first native L1 supporting both WASM and EVM, has recently further optimized the multi-virtual machine environment, allowing developers to easily deploy advanced applications on a single chain.
Ecologically, significant progress has been made with three major partners:
DigiShares: Connecting to the Injective network, tokenizing real-world assets like real estate and Pre-IPO equity through the ERC-7943 standard.
Nansen: The native staking feature with $INJ has attracted over 700,000 INJ staked (worth approximately $2.2 million), which is quite attractive to institutional funds.
Valereum: The collaboration provides a secondary trading platform for publicly listed companies, enhancing the end-to-end experience for RWA.
Unlike other public chains, Injective focuses on DeFi and RWA, and is one of the most active public chains in development over the past year, ranking first among financial public chains.
Currently, Injective's official token INJ has corrected about 80% from its recent yearly high, so it's worth paying more attention; if the market reverses later, it could be a potential stock.
